Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
A Non-Randomized, Open-label Phase II Trial Testing the Activity of XL092 (Zanzalintinib) in Patients With Advanced Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
This phase II trial tests how well zanzalintinib (XL092) works in treating patients with leiomyosarcoma that has spread from where it first started to other pl…
Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaBone Sarcoma+7 more
Estimated
~$10 – $6,250
Northwestern UniversityNCT06571734
Phase 2
A Phase II Open Label Basket Trial Study Using Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Ewing sarcoma (EWS) and osteosarcoma primarily affect adolescents and young adults. Common treatments include chemotherapy, surgery and radiation, however, the…
OsteosarcomaEwing SarcomaEwing Sarcoma Metastatic
Estimated
~$10 – $6,250
Milton S. Hershey Medical CenterNCT07321912
Phase 2
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
The purpose of this research study is to see how metformin, when used in combination with standard of care (SOC) treatment for metastatic (cancer that has spre…
Sarcoma MetastaticSarcoma, Soft Tissue
Estimated
~$10 – $6,250
Wake Forest University Health SciencesNCT07291297